Growth Metrics

Prestige Consumer Healthcare (PBH) EPS (Weighted Average and Diluted): 2009-2025

Historic EPS (Weighted Average and Diluted) for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $0.86.

  • Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) fell 21.10% to $0.86 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.04, marking a year-over-year decrease of 1.70%. This contributed to the annual value of $4.29 for FY2025, which is 2.88% up from last year.
  • As of Q3 2025, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) stood at $0.86, which was down 9.47% from $0.95 recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) ranged from a high of $1.22 in Q4 2024 and a low of -$4.79 during Q1 2023.
  • Over the past 3 years, Prestige Consumer Healthcare's median EPS (Weighted Average and Diluted) value was $1.01 (recorded in 2025), while the average stood at $0.50.
  • In the last 5 years, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) slumped by 569.61% in 2023 and then skyrocketed by 120.46% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) (Quarterly) stood at $0.99 in 2021, then grew by 5.05% to $1.04 in 2022, then climbed by 1.92% to $1.06 in 2023, then climbed by 15.09% to $1.22 in 2024, then dropped by 21.10% to $0.86 in 2025.
  • Its last three reported values are $0.86 in Q3 2025, $0.95 for Q2 2025, and $1.01 during Q1 2025.